Eric Van Den Neste - JoVE Visualize

Showing results (31-40 of 83) with videos related to

Pageof 9

Sort By:

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 25, 2016

No Evidence for the Benefit of Gonadotropin-Releasing Hormone Agonist in Preserving Ovarian Function and Fertility in Lymphoma Survivors Treated With Chemotherapy: Final Long-Term Report of a Prospective Randomized TrialIsabelle Demeestere, Pauline Brice, Fedro A Peccatori, et al.

Leukemia & Lymphoma|August 10, 2013

Quantitative and qualitative analysis of metabolic response at interim positron emission tomography scan combined with International Prognostic Index is highly predictive of outcome in diffuse large B-cell lymphomaNathalie Nols, Nicolas Mounier, Salima Bouazza, et al.

Cancers|June 27, 2024

Recommendations for the Management of Patients with Hairy-Cell Leukemia and Hairy-Cell Leukemia-like Disorders: A Work by French-Speaking Experts and French Innovative Leukemia Organization (FILO) GroupJérôme Paillassa, Elsa Maitre, Nadia Belarbi Boudjerra, et al.

Haematologica|August 4, 2006

High-dose chemotherapy followed by autologous hematopoietic stem cell transplantation for adult histiocytic disorders with central nervous system involvementNathalie Gaspar, Pascaline Boudou, Julien Haroche, et al.

The New England Journal of Medicine|January 25, 2002

CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphomaBertrand Coiffier, Eric Lepage, Josette Briere, et al.

British Journal of Haematology|September 22, 2009

Impaired up-regulation of polo-like kinase 2 in B-cell chronic lymphocytic leukaemia lymphocytes resistant to fludarabine and 2-chlorodeoxyadenosine: a potential marker of defective damage responseEmeline de Viron, Laurent Knoops, Thierry Connerotte, et al.

Cancer Chemotherapy and Pharmacology|December 12, 2012

Acadesine for patients with relapsed/refractory chronic lymphocytic leukemia (CLL): a multicenter phase I/II studyEric Van Den Neste, Bruno Cazin, Ann Janssens, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 7, 2012

Gonadotropin-releasing hormone agonist for the prevention of chemotherapy-induced ovarian failure in patients with lymphoma: 1-year follow-up of a prospective randomized trialIsabelle Demeestere, Pauline Brice, Fedro A Peccatori, et al.

Blood|June 16, 2010

Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d'Etudes des Lymphomes de l'AdulteBertrand Coiffier, Catherine Thieblemont, Eric Van Den Neste, et al.

British Journal of Haematology|October 18, 2005

Activity and safety of combined rituximab with chlorambucil in patients with mantle cell lymphomaDeborah Bauwens, Marie Maerevoet, Lucienne Michaux, et al.

Pageof 9

Showing results (31-40 of 83) with videos related to

Sort By:

Pageof 9

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 25, 2016

No Evidence for the Benefit of Gonadotropin-Releasing Hormone Agonist in Preserving Ovarian Function and Fertility in Lymphoma Survivors Treated With Chemotherapy: Final Long-Term Report of a Prospective Randomized TrialIsabelle Demeestere, Pauline Brice, Fedro A Peccatori, et al.

Leukemia & Lymphoma|August 10, 2013

Quantitative and qualitative analysis of metabolic response at interim positron emission tomography scan combined with International Prognostic Index is highly predictive of outcome in diffuse large B-cell lymphomaNathalie Nols, Nicolas Mounier, Salima Bouazza, et al.

Cancers|June 27, 2024

Recommendations for the Management of Patients with Hairy-Cell Leukemia and Hairy-Cell Leukemia-like Disorders: A Work by French-Speaking Experts and French Innovative Leukemia Organization (FILO) GroupJérôme Paillassa, Elsa Maitre, Nadia Belarbi Boudjerra, et al.

Haematologica|August 4, 2006

High-dose chemotherapy followed by autologous hematopoietic stem cell transplantation for adult histiocytic disorders with central nervous system involvementNathalie Gaspar, Pascaline Boudou, Julien Haroche, et al.

The New England Journal of Medicine|January 25, 2002

CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphomaBertrand Coiffier, Eric Lepage, Josette Briere, et al.

British Journal of Haematology|September 22, 2009

Impaired up-regulation of polo-like kinase 2 in B-cell chronic lymphocytic leukaemia lymphocytes resistant to fludarabine and 2-chlorodeoxyadenosine: a potential marker of defective damage responseEmeline de Viron, Laurent Knoops, Thierry Connerotte, et al.

Cancer Chemotherapy and Pharmacology|December 12, 2012

Acadesine for patients with relapsed/refractory chronic lymphocytic leukemia (CLL): a multicenter phase I/II studyEric Van Den Neste, Bruno Cazin, Ann Janssens, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 7, 2012

Gonadotropin-releasing hormone agonist for the prevention of chemotherapy-induced ovarian failure in patients with lymphoma: 1-year follow-up of a prospective randomized trialIsabelle Demeestere, Pauline Brice, Fedro A Peccatori, et al.

Blood|June 16, 2010

Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d'Etudes des Lymphomes de l'AdulteBertrand Coiffier, Catherine Thieblemont, Eric Van Den Neste, et al.

British Journal of Haematology|October 18, 2005

Activity and safety of combined rituximab with chlorambucil in patients with mantle cell lymphomaDeborah Bauwens, Marie Maerevoet, Lucienne Michaux, et al.

Pageof 9